Dengue Virus Inhibition Targets: A Review and Docking Study

Area of Science:

• Tropical Medicine
• Vector Biology
• Computational Chemistry

Background:

• Dengue, a neglected tropical disease, is transmitted by Aedes mosquitoes, with severe cases manifesting as dengue hemorrhagic fever.
• Current dengue control methods include targeting viral components (NS2B-NS3 protease, protein E) and vector survival mechanisms.
• Mosquito cuticle sclerotization is vital for vector survival and presents a potential target for novel control strategies.

Purpose of the Study:

• To investigate the potential of inhibiting mosquito cuticle sclerotization as a dengue control strategy.
• To evaluate the in silico efficacy of 27 myricetin analogs against the arylalkylamine N-acetyltransferase (aaNAT) enzyme involved in sclerotization.

Main Methods:

• Computational methods including molecular docking, functional density analysis, and molecular orbital energy calculations were employed.
• Analysis focused on the interactions between myricetin analogs and target proteins involved in mosquito cuticle formation.
• In silico screening of 27 myricetin analogs was performed to assess their inhibitory potential.

Main Results:

• Several myricetin analogs demonstrated significant interactions with target proteins involved in mosquito cuticle sclerotization.
• The in silico results indicate that myricetin analogs can potentially disrupt the sclerotization process in Aedes mosquitoes.
• The study identified specific analogs with promising activity against the arylalkylamine N-acetyltransferase (aaNAT) pathway.

Conclusions:

• Inhibiting mosquito cuticle sclerotization via compounds like myricetin analogs offers a promising new avenue for dengue vector control.
• Further research and in vitro/in vivo validation are warranted to confirm the efficacy of these myricetin analogs.
• Targeting vector-specific biological processes presents a sustainable approach to managing arboviral disease transmission.